CHICAGO, Dec. 12, 2023 (GLOBE NEWSWIRE) Vanqua Bio today announced that its development candidate VQ-101, a best-in-class brain-penetrant small molecule allosteric activator of glucocerebrosidase (GCase), will enter clinical development
Sara Nayeem, M D , Experienced Biopharmaceutical Venture Investor, Joins Enavate Sciences as Executive Vice President, Investments lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Avoro Ventures Adds Mark Chin as a Partner tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Benjamin Oakes Scribe Therapeutics is developing specialized Crispr proteins for multiple diseases–and it’s got deals with Big Pharma potentially worth over $4 billion